USPTO serial 79381826
S
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Nov 26, 2024
- Examiner
- MARTIN, CHRISTINE C
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with S?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Randolph E. Digges, III
Randolph E. Digges, III Rankin, Hill & Clark LLPP.O. Box 1150Bonita Springs, FL 34133-1150United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemicals used in industry and science, in particular active substances, auxiliaries and intermediate products for chemicals and types of chemicals; chemicals used in industry, namely, for the cosmetics industry; excipients being inert bases for the manufacture of pharmaceutical preparations; excipients for use in the manufacture of medical and veterinary preparations | ACTIVE | — |
| 002 | Colors, dyes, colorants, namely, colorants and additives in the nature of coloring and dyes for the manufacture of foodstuffs and food supplements | ACTIVE | — |
| 003 | Cosmetic non-medicated products, namely, cosmetic preparations, make-up; body care and beauty products, namely, body and beauty care cosmetics | ACTIVE | — |
| 005 | Pharmaceutical products, namely, cardiovascular pharmaceutical preparations, antimycotic agents, antifungal agents, anticoagulant agents, anticancer drugs, analgesics, anorexiants, anticonvulsants, antiemetics, anti-Parkinson's, anticarcinoma, anxiolytics, sedatives and hypnotics, cholinergic agonists, cholinesterase inhibitors, CNS stimulants, general anesthetics, muscle relaxants, oral hypoglycemic agents, oral antihyperglycemic agents, biguanides, sulfonylureas, meglitinides, dipeptidyl peptidase-4 (DPP-4) inhibitors, sodium-glucose co-transporter 2 (SGLT2) inhibitors, thiazolidinediones (TZDs), and alpha-glucosidase inhibitors; active substances (APIs), drug substance intermediates (DSIs) and excipients for medicines and pharmaceutical products, namely, active pharmaceutical ingredients and drug substance intermediates all being pharmaceutical preparations and substances for the treatment of amyloidosis, pulmonary hypertension, spinal muscular atrophy, oncological diseases and conditions, diseases and conditions of the central nervous system, and diabetes; medical and veterinary preparations for the treatment of amyloidosis, pulmonary hypertension, spinal muscular atrophy, oncological diseases and conditions, diseases and conditions of the central nervous system, and diabetes; active substances and intermediate products for medical and veterinary preparations , namely, pharmaceutical preparations and substances for the treatment of amyloidosis, pulmonary hypertension, spinal muscular atrophy, oncological diseases and conditions, diseases and conditions of the central nervous system, and diabetes; dietetic foods and beverages for medical or veterinary purposes; food ingredients and additives being dietetic foods and beverages adapted for medical use; food for babies; ingredients and additives being food for babies food supplements for humans and animals; ingredients and additives being food supplements | ACTIVE | — |
| 039 | Transport services, namely, transportation of goods; packaging and storage of merchandise, in particular packaging, storage and transport of raw materials for the pharmaceutical and food industry as well as finished generic pharmaceutical products | ACTIVE | — |
| 042 | Scientific and technological services, namely, development of generic medicine products; industrial analysis, quality control and authentication services, particularly for the pharmaceutical and nutritional industry in the fields of quality assurance and analysis, regulatory authorization and regulatory affairs | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Selectchemie AG
- Other trademarks owned by Selectchemie AG
- Other trademarks owned by Selectchemie AG
- Other trademarks in Class 001
- Other trademarks in Class 002
- Other trademarks in Class 003
- Other trademarks in Class 005
- Other trademarks in Class 039
- Other trademarks in Class 042
- Similar marks named S
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 17, 2025 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Apr 24, 2025 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Apr 24, 2025 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Apr 12, 2025 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Mar 25, 2025 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Mar 25, 2025 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Feb 26, 2025 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Nov 26, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Nov 26, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 24, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 24, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 4, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Aug 20, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 14, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 14, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 14, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 8, 2024 | RFNT | REFUSAL PROCESSED BY IB | — |
| Apr 17, 2024 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Apr 16, 2024 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Mar 29, 2024 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Mar 28, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 28, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 11, 2023 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Nov 7, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 26, 2023 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |